Glooko reports no severe hypoglycaemia in 267-patient EndoTool IV labour and delivery analysis
Glooko reports zero severe hypoglycaemia events in 267 patients using EndoTool IV during delivery, but neonatal outcomes remain unreported.
Glooko reports zero severe hypoglycaemia events in 267 patients using EndoTool IV during delivery, but neonatal outcomes remain unreported.
Insulin dosing is moving to the cloud. Glooko’s FDA clearance raises bigger questions on hospital workflow, safety, and scale.